Found 5 matching trials
Nicotine Pharmacokinetic Profile and Safety of the Tobacco Heating System 2.2 Menthol (THS 2.2 Menthol)
NAThe primary objective of the study is to evaluate the pharmacokinetic (PK) ...
Location
Central Kentucky Research Associates
Reduced Exposure Study Using THS 2.2 Menthol With 5 Days in a Confinement Setting and 85 Days in an Ambulatory Setting
NAThe main goal of the study is to evaluate if the ad libitum use of the THS ...
Location
Osaki Hospital Tokyo Heart Center, 5-4-12, Kitashinagawa, Shinagawa-ku
Nicotine Pharmacokinetic Profile and Safety of the Tobacco Heating System 2.2 Menthol (THS 2.2 Menthol).
NAThe primary objective of this clinical study is to evaluate the pharmacokin...
Location
Ageo Medical Clinic, 3133 Haraichi, Ageo-shi
Reduced Exposure Study Using THS 2.2 Menthol With 5 Days in a Confinement Setting Followed by 86 Days in an Ambulatory Setting
NAEvaluate if the ad libitum use of the THS 2.2 Menthol (mTHS), a candidate M...
Location
Covance Daytona Beach, 1900 Mason Ave., Suite 140
Nicotine Pharmacokinetic Profile of the CHTP 1.1 M
NAThe primary objective of this clinical study is to evaluate the pharmacokin...
Location
Ageo Medical Clinic